Actinium Pharmaceuticals, Inc. (ATNM): Operating Income
-$36.25M
Year ended 2025-12-31
$9.56M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$36.25M | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | -$42.12M | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$51.92M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$34.10M | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | -$24.96M | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$22.39M | n/m | 2022-03-25, From 2020-01-01 |
| 2019-12-31 | -$22.07M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$23.83M | n/m | 2020-05-08, From 2018-01-01 |
| 2017-12-31 | -$26.91M | n/m | 2019-03-15, From 2017-01-01 |
| 2016-12-31 | -$26.85M | n/m | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | -$24.83M | n/m | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | -$22.48M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$6.59M | n/m | 2016-03-11, From 2013-01-01 |
| 2012-12-31 | -$7.95M | n/m | 2014-02-28, From 2012-01-01 |
| 2011-12-31 | -$3.28M | n/m | 2013-03-29, From 2011-01-01 |
| 2010-12-31 | -$26.1K | n/a | 2012-04-12, From 2010-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | -$36.25M | n/m |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | -$23.79M | n/m |
| iBio, Inc. (IBIO) | 2026-06-30 | -$35.14M | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | -$4.28M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$6.59M | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | -$86.82M | n/m |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | -$58.07M | n/m |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$24.02M | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$72.92M | n/m |
Compare ATNM, IXHL, IBIO, SILO side by side · Screen every company in Pharmaceutical Preparations ↗